• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Galectin Therapeutics Inc

+ Add to Watchlist


10.189 EUR 0.391 3.99%

As of 08:36:57 ET on 07/22/2014.

Snapshot for Galectin Therapeutics Inc (PHPN)

Open: 9.798 Day's Range: 9.798 - 10.189 Volume: 1,000
Previous Close: 9.798 52wk Range: 3.621 - 13.604 1-Yr Rtn: +178.01%

Stock Chart for PHPN

No chart data available.
  • PHPN:GR 10.189
  • 1D
  • 1M
  • 1Y
Interactive PHPN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHPN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.8400
Est. PEG Ratio -
Market Cap (M EUR) 223.22
Shares Outstanding (M) 21.91
30 Day Average Volume 121
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHPN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PHPN

Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate technology that targets galectin proteins which are key mediators of biologic and pathologic functions. Gelectin uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates.

James C CzirrChairman/Co-FounderPeter G TraberPresident/CEO/Chief Medical Ofcr
Jack W CallicuttChief Financial OfficerHarold H ShlevinChief Operating Officer
More Company Profile & Key Executives for PHPN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil